Join us for an in-person experience to interact with GI Cancer experts from the Asia-Pacific region and global key opinion leaders assessing and presenting their studies.


APGCS – a Singaporean grown meeting which started in 2013 has developed into a curated platform for showcasing real world case discussions, breakthrough research and data from the front-line of GI Cancer Care.

APGCS 2024 will continue to work towards a state of art scientific program and engage audiences with some of the most important and recent discussions via key notes from global leaders, clinical practice experience from regional experts and engaging multidisciplinary tumor boards.

"Supported By"

View our Past Events

Day 2 of APGCS 2022 highlights Sessions on Pancreatic Tumors, Neuro Endocrine Tumors and Colorectal Cancers.

APGCS 2022 is back to Singapore after 2 years and was presented on a Hybrid Format! Day 1 of APGCS highlights Sessions on Precision Oncology in GI Malignancies, Esophageal and Gastric Cancers and Hepatobiliary Malignancies. It also features a panel discussion where global key opinion leaders from different parts of the globe come together to discuss and assess studies.

The inaugural session on Day 1 of the  APGCS features speakers from different parts of the globe, the event was opened with a Keynote on Gi Malignancies followed by Immunotherapy in upper GI and gastric Cancer.

The 2nd session on Day 1 of the  APGCS features 6 speakers from different parts of the globe, the focused on “ESOPHAGEAL AND GASTRIC CANCERS”, with speakers from Singapore, Uk and the US.

The 3rd session on Day 1 of the  APGCS features 11 speakers from different parts of the globe, the focused on Hepatobiliary Malignancies, it also featured a Debate alone with a round table discussion and Molecular Tumor Boards.


The 4th Session   was started with a welcome note from Dr.  Shaheenah Dawood from UAE which was followed by the  Session on Biomarkers and Novel Agents Chaired by Dr.Muhammad Azrif from Malaysia and speakers Asad Umar, USA, Eileen O’Reilly, USA and Axel Grothey, USA


The 5th Session  focused on the Esophageal and Gastric Tumor Board Chaired by Dr. Matthew Ng, Singapore, with Case Presenters: Raghav Sunder, Singapore & Rachel Wong, Singapore |Connie Yip, Singapore & Janice Tan, Singapore and Panelist: Sanjay Sharma, India | Choo Su Pin, Singapore |Joe Yeong, Singapore. followed by two speakers Matthew Ng, Singapore and Choo Su Pin, Singapore


The 6th Session was Chaired by Dr Toh Han Chong, Singapore on the Colorectal Cancer Tumor Board, the cases were presented by Dr Axel Grothey, USA and Dr  Iain Tan, Singapore with Panellist Dr Muhammad Azrif, Malaysia, Dr Kai-Keen Shiu, UK, Dr.  Shona Nag, India  and Dr Bhawna Sirohi, India.


The Opening Session of APGCS  was started with a welcome and keynote from Dr.  Toh Han Chong from Singapore. which was followed by the  GI Molecular Tumor board moderated by Dr. Axel Grothey from USA with panellist Dr. Bhawna Sirohi from India, Dr. Tobias Arkenau from UK, Dr. Nitesh Rohatgi from India and Dr. Joe Yeong, Singapore. followed by a session from Dr. Shaheenah Dawood from UAE


Session 2: The 2nd Session of APGCS  was chaired by Dr, Chee Cheng Ean from Singapore at 17:50hrs Singapore Time, with Dr. Ghassan Abou-Alfa from USA,  Dr. Sun Young Rha from South Korea and Dr. Axel Grothey from the USA


The 3rd Session of APGCS  was chaired by Bhawna Sirohi from India with speakers Dr. Changhoon Yoo from S. Korea and  Dr. Joon Oh Park from S. Korea. followed by the Hepatobiliary & Pancreatic Cancer Tumor Board which was moderated by Dr. Toh Han Chong from Singapore, case studies by Shailesh Shrikhande, India | Thomas Yau, Hong Kong | Pierce Chow, Singapore and panelist Bhawna Sirohi, India | Chiun Hsu, Taiwan |
Ghassan Abou-Alfa, USA | Nitesh Rohatgi, India

Disclaimer :

This site does not recommend, endorse or promote any particular management approach, methodology or treating agents. The views expressed by various experts are their own.